Palomar Medical Tech (PMTI) Reports Mixed Q4 Results
PMTI Hot Sheet
Revenue Growth %: +4.4%Financial Fact:
Selling and marketing: 6.68M
Today's EPS Names:
TARO, BRLI, TLB, More
Palomar Medical Tech (NASDAQ: PMTI) reported Q4 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $23 million versus the consensus estimate of $26.03 million.
For earnings history and earnings-related data on Palomar Medical Tech (PMTI) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Palomar Medical Tech (PMTI) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Global Hunter Securities Starts Kosmos Energy (KOS) at Buy; High Risk, High Reward
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
